Progyny (NASDAQ:PGNY) Issues Q4 2024 Earnings Guidance

Progyny (NASDAQ:PGNY) issued an update on its fourth quarter 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.310-0.350 for the period, compared to the consensus earnings per share estimate of 0.140. The company issued revenue guidance of $266.2 million-$281.2 million, compared to the consensus revenue estimate of $292.7 million. Progyny also updated its FY 2024 guidance to 1.540-1.570 EPS.

Analyst Ratings Changes

PGNY has been the subject of a number of research analyst reports. Leerink Partnrs lowered shares of Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. JMP Securities lowered shares of Progyny from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 19th. Jefferies Financial Group lowered their price target on Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. BTIG Research cut Progyny from a “buy” rating to a “neutral” rating in a research report on Wednesday, August 7th. Finally, Bank of America lowered their target price on Progyny from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Wednesday. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $25.42.

Progyny Stock Up 0.6 %

PGNY stock opened at $13.98 on Friday. Progyny has a 52 week low of $13.77 and a 52 week high of $42.08. The firm has a market capitalization of $1.19 billion, a P/E ratio of 24.10, a price-to-earnings-growth ratio of 1.31 and a beta of 1.44. The company has a fifty day simple moving average of $17.49 and a two-hundred day simple moving average of $23.49.

Progyny (NASDAQ:PGNY) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The company had revenue of $286.63 million during the quarter, compared to the consensus estimate of $296.85 million. Progyny had a net margin of 5.03% and a return on equity of 11.36%. Progyny’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.16 earnings per share. As a group, analysts anticipate that Progyny will post 0.64 EPS for the current year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.